Showing results (331-340 of 472) with videos related to
Sort By:
Pageof 48
JAMA|September 9, 1988
Lack of efficacy of Haemophilus b polysaccharide vaccine in MinnesotaM T Osterholm, J H Rambeck, K E White, et al.The Journal of Infectious Diseases|May 2, 2016
Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV InfectionÁlvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.The Journal of Infectious Diseases|October 15, 2010
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa, Andrew Ratsela, Michael Polis, et al.Proceedings of the National Academy of Sciences of the United States of America|March 8, 2017
Solar fuels photoanode materials discovery by integrating high-throughput theory and experimentQimin Yan, Jie Yu, Santosh K Suram, et al.Journal of the American Chemical Society|April 29, 2010
Conductance and geometry of pyridine-linked single-molecule junctionsM Kamenetska, Su Ying Quek, A C Whalley, et al.Journal of the American Chemical Society|July 27, 2019
Water Enables Efficient CO<sub>2</sub> Capture from Natural Gas Flue Emissions in an Oxidation-Resistant Diamine-Appended Metal-Organic FrameworkRebecca L Siegelman, Phillip J Milner, Alexander C Forse, et al.AIDS (London, England)|July 9, 2014
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV diseaseÁlvaro H Borges, Jeffrey I Weitz, Gary Collins, et al.Journal of Cardiac Failure|June 11, 2005
Clinical and analytical considerations in the study of health status in device trials for heart failureSharon-Lise T Normand, Thomas S Rector, James D Neaton, et al.The Journal of Infectious Diseases|May 20, 2011
Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or deathDavid R Boulware, Katherine Huppler Hullsiek, Camille E Puronen, et al.Clinical Trials (London, England)|May 2, 2012
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) studyAbdel G Babiker, Sean Emery, Gerd Fätkenheuer, et al.Pageof 48